Multaq (Physicians Total Care, Inc.)


Welcome to the PulseAid listing for the Multaq drug offered from Physicians Total Care, Inc.. This Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Physicians Total Care, Inc.
NON-PROPRIETARY NAME: Dronedarone
SUBSTANCE NAME: DRONEDARONE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-02-23
END MARKETING DATE: 0000-00-00


Multaq HUMAN PRESCRIPTION DRUG Details:

Item DescriptionMultaq from Physicians Total Care, Inc.
LABELER NAME: Physicians Total Care, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 400(mg/1)
START MARKETING DATE: 2010-02-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54868-3086_66ea5793-f691-4217-9a37-39690a7a3f69
PRODUCT NDC: 54868-3086
APPLICATION NUMBER: NDA022425

Other DRONEDARONE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Cardinal HealthMultaq
Physicians Total Care, Inc.Multaq
Sanofi Winthrop IndustriesMultaq
sanofi-aventis U.S. LLCMultaq